| AML | Acute myeloid leukemia |
| allo-HSCT | Allogeneic hematopoietic stem cell transplantation |
| BM | Bone marrow |
| CR | Complete remission |
| DEGs | Differentially expressed genes |
| ES | Enrichment score |
| FAB | The French–American–British classification |
| GBP1 | Guanylate-binding protein |
| IFN | Interferon |
| IPA | Ingenuity pathway analysis |
| ISGs | Interferon stimulated genes |
| L-TME | Leukemic bone marrow tumor microenvironment |
| MRD | minimal residual disease |
| OS | Overall survival |
| PARP12 | Poly-ADP-ribose-polymerase-12 enzyme |
| PB | Peripheral blood |
| RNA-Seq/mRNA-Seq | mRNA-sequencing |
| ssGSEA | Single-sample gene set enrichment analysis |
| TARGET | Therapeutically Applicable Research to Generate Effective Treatments |
| TH1 | T helper 1 |
| TME | Tumor microenvironment |
| TRAT1 | T-cell receptor-associated transmembrane adapter |
| tSNE | t-distributed stochastic neighbor embedding |
| WHO | World Health Organization |